Sporadic and Familial Cerebral Amyloid Angiopathies

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Brain Pathology

• Publication date

  2002-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1750-3639.2002.tb00449.xPMID 12146803PMCID PMC8095796
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Skin deposits in hereditary cystatin C amyloidosis

  2005cited by this paper
• Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition

  2004cited by this paper
• Cortical angiopathy in Alzheimer's disease: The formation of dystrophic perivascular neurites is related to the exudation of amyloid fibrils from the pathological vessels

  2004cited by this paper
• Familial Danish Dementia: A Novel Form of Cerebral Amyloidosis Associated with Deposition of Both Amyloid‐Dan and Amyloid‐Beta

  2002influential reference
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation

  2001cited by this paper
• Shattuck lecture--neurodegenerative diseases and prions.

  2001cited by this paper
• Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy

  2001cited by this paper
• Codeposition of Cystatin C with Amyloid‐β Protein in the Brain of Alzheimer Disease Patients

  2001cited by this paper
• Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.

  2001cited by this paper
• A Pathogenic Presenilin-1 Deletion Causes Abberrant Aβ42 Production in the Absence of Congophilic Amyloid Plaques*

  2001cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

  2001cited by this paper
• Systemic Amyloid Deposits in Familial British Dementia*

  2001influential reference
• Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation.

  2001cited by this paper
• Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia.

  2001influential reference
• Chromosome 13 dementia syndromes as models of neurodegeneration

  2001influential reference
• Familial cerebral amyloid angiopathy related to stroke and dementia.

  2001cited by this paper
• Vascular Transport of Alzheimer’s Amyloid β Peptides and Apolipoproteins

  2000cited by this paper
• Neuropathologic Features and Grading of Alzheimer-Related and Sporadic CAA

  2000cited by this paper
• Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells.

  2000cited by this paper
• CAA in Transgenic Mouse Models of Alzheimer’s Disease

  2000cited by this paper
• Clinical Aspects and Diagnostic Criteria of Sporadic CAA-Related Hemorrhage

  2000cited by this paper
• APOE Genotype in Relation to Sporadic and Alzheimer-Related CAA

  2000cited by this paper
• A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred.

  2000influential reference
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.

  2000cited by this paper
• Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease.

  2000cited by this paper
• Senile dementia associated with amyloid β protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-ε4 allele

  2000cited by this paper
• Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

  2000cited by this paper
• A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease

  2000cited by this paper
• Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.

  2000cited by this paper
• Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings.

  2000cited by this paper
• Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS‐1 mutations that lead to exceptionally high amyloid‐β concentrations

  2000cited by this paper
• Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls.

  1999cited by this paper
• Amyloid β precursor protein-mRNA is expressed throughout cerebral vessel walls

  1999cited by this paper
• Gelsolin‐related spinal and cerebral amyloid angiopathy

  1999influential reference
• Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.

  1999cited by this paper
• A stop-codon mutation in the BRI gene associated with familial British dementia

  1999influential reference
• Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease.

  1999cited by this paper
• Ultrastructural evidence of early non-fibrillar Aβ42 in the capillary basement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type

  1999cited by this paper
• Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia

  1999influential reference
• A novel Polish presenilin‐1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years

  1998cited by this paper
• Cerebrovascular Accumulation and Increased Blood‐Brain Barrier Permeability to Circulating Alzheimer's Amyloid β Peptide in Aged Squirrel Monkey with Cerebral Amyloid Angiopathy

  1998cited by this paper
• Amyloid angiopathy in a volga german family with Alzheimer's disease and a presenilin‐2 mutation (N141I)

  1998cited by this paper
• Cell-Type-Specific Enhancement of Amyloid-β Deposition in a Novel Presenilin-1 Mutation (P117L)

  1998cited by this paper
• Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide.

  1998cited by this paper
• High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage.

  1998cited by this paper
• Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.

  1998cited by this paper
• Distribution of Aβ-associated proteins in cerebrovascular amyloid of Alzheimer’s disease

  1998cited by this paper
• Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy

  1998cited by this paper
• A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1

  1998cited by this paper
• Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy.

  1998cited by this paper
• Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer's disease.

  1998cited by this paper
• Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.

  1998cited by this paper
• Progression of Cerebral Amyloid Angiopathy: Accumulation of Amyloid-ß40 in Affected Vessels

  1998cited by this paper
• N‐terminal Heterogeneity of Parenchymal and Cerebrovascular Aβ Deposits

  1998cited by this paper
• Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies.

  1997cited by this paper
• High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy

  1997cited by this paper
• A novel missense mutation in the presenilin-1 gene in a familial Alzheimer's disease pedigree with abundant amyloid angiopathy.

  1997cited by this paper
• Alzheimer's soluble amyloid beta is a normal component of human urine.

  1997cited by this paper
• Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

  1997cited by this paper
• Transthyretin amyloidosis: A new mutation associated with dementia

  1997cited by this paper
• Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.

  1997cited by this paper
• Alzheimer's soluble amyloid β is a normal component of human urine

  1997cited by this paper
• Preferential deposition of amyloid β protein (Aβ) in the form Aβ40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele

  1997cited by this paper
• The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant

  1996cited by this paper
• Leptomeningeal amyloid and variant transthyretins.

  1996influential reference
• Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.

  1996cited by this paper
• Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease.

  1996cited by this paper
• Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques.

  1996cited by this paper
• The Molecular Pathology of Hereditary Cystatin C Amyloid Angiopathy Causing Brain Hemorrhage

  1996influential reference
• The length of Amyloid-β in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type

  1996cited by this paper
• The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease.

  1996cited by this paper
• Apolipoprotein E and amyloidogenesis.

  1996cited by this paper
• Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly)

  1996cited by this paper
• Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)

  1996cited by this paper
• Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay*

  1996cited by this paper
• Review: David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines *

  1996cited by this paper
• Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease

  1996cited by this paper
• Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch Type (HCHWA‐D): I ‐ A Review of Clinical, Radiologic and Genetic Aspects

  1996cited by this paper
• Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch type (HCHWA‐D): II ‐ A Review of Histopathological Aspects

  1996cited by this paper
• Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

  1996cited by this paper
• Brain Parenchymal and Microvascular Amyloid in Alzheimer's Disease

  1996cited by this paper
• Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP.

  1996influential reference
• Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.

  1996cited by this paper
• Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro.

  1995cited by this paper
• Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain

  1995cited by this paper
• Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.

  1995cited by this paper
• Candidate gene for the chromosome 1 familial Alzheimer's disease locus

  1995cited by this paper
• Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in Vitro(*)

  1995cited by this paper
• Amyloid β‐Protein Induces Its Own Production in Cultured Degenerating Cerebrovascular Smooth Muscle Cells

  1995cited by this paper
• Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy

  1995cited by this paper
• Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells.

  1995cited by this paper
• Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

  1995cited by this paper
• Transthyretin mutations in health and disease

  1995influential reference
• Familial cerebral amyloid angiopathy (British type) with nonneuritic amyloid plaque formation may be due to a novel amyloid protein.

  1995cited by this paper
• Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

  1994cited by this paper
• Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

  1994cited by this paper
• Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides.

  1994cited by this paper
• Unifying features of systemic and cerebral amyloidosis

  1994cited by this paper
• Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF).

  1994influential reference

• Age-related macular degeneration and cerebral amyloid angiopathy have similar pathologies from cholesterol-APOE-amyloid-β-complement mediated inflammation.

  2026cites this paper
• Intrahippocampally Injected Human Recombinant Clusterin Reduces Amyloid‐β Aggregate Size in Cerebral Arteriole Walls of Clusterin Knockout Mice

  2025cites this paper
• The integrity of perivascular spaces is absolutely essential for proper function of the glymphatic system waste and excess water removal from the brain.

  2025cites this paper
• Antioxidants Trolox and Methazolamide Protect Microvascular Endothelial Cells from Oxidative Damage Induced by Sporadic and Familial Forms of Oligomeric Amyloid-β

  2025cites this paper
• Lipid mediated formation of antiparallel aggregates in cerebral amyloid angiopathy

  2025cites this paper
• Amyloid-β (Aβ) immunotherapy induced microhemorrhages are linked to vascular inflammation and cerebrovascular damage in a mouse model of Alzheimer’s disease

  2024cites this paper
• Brain endothelial cell activation and dysfunction associate with and contribute to the development of enlarged perivascular spaces and cerebral small vessel disease.

  2024cites this paper
• Pathways to Alzheimer’s Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health

  2024cites this paper
• Input of exome sequencing in early‐onset cerebral amyloid angiopathy

  2024cites this paper
• Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome

  2024cites this paper
• Familial cerebral amyloid disorders with prominent white matter involvement.

  2024cites this paper
• State-of-the-Art of Transcatheter Left Atrial Appendage Occlusion

  2024cites this paper
• A Closer Look at the Perivascular Unit in the Development of Enlarged Perivascular Spaces in Obesity, Metabolic Syndrome, and Type 2 Diabetes Mellitus

  2024cites this paper
• Cerebral amyloid angiopathy-related cardiac injury: Focus on cardiac cell death

  2023cites this paper
• Intermediate Antiparallel Fibrils in Aβ40 Dutch Mutant Aggregation: Insights from Nanoscale Infrared Spectroscopy.

  2023cites this paper
• The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue

  2023cites this paper
• Evaluation of Copper Chelation Therapy in a Transgenic Rat Model of Cerebral Amyloid Angiopathy.

  2023cites this paper
• Role of cortical superficial siderosis in Forensic Neuropathology: two cases of autopsies

  2023cites this paper
• Intermediate antiparallel fibrils in Aβ40 Dutch mutant aggregation: nanoscale insights from AFM-IR

  2023cites this paper
• Clinical considerations in early-onset cerebral amyloid angiopathy

  2023cites this paper
• Cerebral Small Vessel Disease: a Review of the Pathophysiological Mechanisms

  2023cites this paper
• Running title: Amyloid angiopathy and vascular brain lesions

  2022cites this paper
• Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions

  2022cites this paper
• Sex Differences in the Long-Term Consequences of Stroke.

  2022cites this paper
• Main features of hereditary cerebral amyloid angiopathies: A systematic review

  2022cites this paper
• Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives

  2022cites this paper
• Implication of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Its Inhibitors in Alzheimer’s Disease Murine Models

  2021cites this paper
• Prediction of hematoma expansion in spontaneous intracerebral hemorrhage: Our institutional experience.

  2021cites this paper
• Assessing the Evolution of Intracranial Hematomas by using Animal Models: A Review of the Progress and the Challenges

  2021cites this paper
• Neuropathology of Alzheimer’s Disease

  2021cites this paper
• Imaging of Cerebral Microbleeds: Primary Patterns and Differential Diagnosis

  2021cites this paper
• SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer’s Disease

  2021cites this paper
• Role of Neuron and Glia in Alzheimer’s Disease and Associated Vascular Dysfunction

  2021cites this paper
• Multiple intracerebral hemorrhages associated with lipohyalinosis: a case report

  2020cites this paper
• Potential Role of Venular Amyloid in Alzheimer’s Disease Pathogenesis

  2020influential citation
• Osteopontin and phospho‐SMAD2/3 are associated with calcification of vessels in D‐CAA, an hereditary cerebral amyloid angiopathy

  2019cites this paper
• Cerebral Amyloid Angiopathy, Alzheimer’s Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets

  2019cites this paper
• Fluid-Blood Level and Hematoma Expansion in a Cerebral Amyloid Angiopathy-Associated Intracerebral Hematoma

  2019cites this paper
• The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy

  2019influential citation
• Canine Cognitive Dysfunction and Alzheimer’s Disease – Two Facets of the Same Disease?

  2019cites this paper
• Cerebral amyloid angiopathy: Review of clinico‐radiological features and mimics

  2018cites this paper
• Pathological examination of cerebral amyloid angiopathy in patients who underwent removal of lobar hemorrhages

  2018cites this paper
• Review: Vascular dementia: clinicopathologic and genetic considerations

  2018cites this paper
• Preparation and Culturing of Human Primary Vascular Cells.

  2018cites this paper
• The pathological hallmarks of Alzheimer’s disease derive from compensatory responses to NMDA receptor insufficiency

  2018cites this paper
• NEUROPATHOLOGICAL AND GENETIC DETERMINANTS OF DEMENTIA: A PROSPECTIVE AND POPULATION-BASED STUDY ON VERY ELDERLY FINNS

  2018cites this paper
• Pathophysiology of Primary Intracerebral Hemorrhage: Insights into Cerebral Small Vessel Disease

  2018cites this paper
• Could Alzheimer’s Disease Originate in the Periphery and If So How So?

  2018cites this paper
• Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways

  2017cites this paper
• Histological and immunohistochemical characteristics of cerebral amyloid angiopathy in elderly dogs

  2017influential citation
• Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease

  2017cites this paper
• Altered Heparan Sulfate in Ageing and Dementia: a Potential Axis for the Dysregulation of BACE-1 in Alzheimer's disease

  2017cites this paper
• Animal models of cerebral amyloid angiopathy.

  2017cites this paper
• Animal models of spontaneous intracerebral hemorrhage

  2016cites this paper
• Hypertension and Dementia: Epidemiological and Experimental Evidence Revealing a Detrimental Relationship

  2016cites this paper
• Metabolic changes may precede proteostatic dysfunction in a Drosophila model of amyloid beta peptide toxicity

  2016cites this paper
• Statin Therapy and the Development of Cerebral Amyloid Angiopathy—A Rodent in Vivo Approach

  2016cites this paper
• The Putative Use of Lithium in Alzheimer's Disease.

  2016cites this paper
• Imaging of Neurotransmitter Systems in Dementia

  2016cites this paper
• Consequences of Intracellular Amyloid in Vascular System

  2016cites this paper
• Observations on cerebral amyloid angiopathy and microvascular pathology in Alzheimer ' s disease and vascular dementia

  2016cites this paper
• Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease.

  2016cites this paper
• The Pathophysiology of Intracerebral Hemorrhage Formation and Expansion

  2015cites this paper
• Cerebral Amyloid Angiopathy, Subcortical White Matter Disease and Dementia: Literature Review and Study in OPTIMA

  2015cites this paper
• Cerebral convexity subarachnoid hemorrhage: various causes and role of diagnostic imaging

  2015cites this paper
• Phagocytes mononucléaires dans la maladie d'Alzheimer : caractérisation et stimulation de mécanismes cellulaires promouvant l'élimination de bêta-amyloïde

  2015cites this paper
• Applied clinical neuroimaging in cerebral amyloid angiopathy and spontaneous intracerebral haemorrhage

  2015cites this paper
• Risk factors of cerebral microbleeds in strictly deep or lobar brain regions differed.

  2015cites this paper
• Gene expression and epigenetics in Hereditary Cystatin C Amyloid Angiopathy. Modulation of histone acetylation and measurements of microRNA levels

  2015influential citation
• Interaction between therapeutic interventions for Alzheimer’s disease and physiological Aβ clearance mechanisms

  2015cites this paper
• Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice

  2015cites this paper
• 18 – Genetic Basis of Stroke Occurrence, Prevention and Outcome

  2015cites this paper
• A representative case of hereditary transthyretin amyloidosis complicated by intramyocardial hemorrhage

  2015cites this paper
• Risk Factors of Dilated Virchow-Robin Spaces Are Different in Various Brain Regions

  2014cites this paper
• Prognostic Value of Plasma &bgr;-Amyloid Levels in Patients With Acute Intracerebral Hemorrhage

  2014cites this paper
• Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes

  2014cites this paper
• Critical Review on the Relationship between Glaucoma and Alzheimer's Disease

  2014cites this paper
• 99mTc-labeled benzothiazole and stilbene derivatives as imaging agents for Aβ plaques in cerebral amyloid angiopathy

  2014cites this paper
• Transmigration of amyloid-β specific heavy chain antibody fragments across the in vitro blood-brain barrier Chapter

  2014cites this paper
• Cerebral Amyloid Angiopathy -Related Inflammation (CAA-ri): Is Steroid/Imunosuppressive Therapy Beneficial?

  2014cites this paper
• Treatment of intracerebral hemorrhage associated with new oral anticoagulant use: the neurologist's view.

  2014cites this paper
• A Caenorhabditis elegans model system for amylopathy study.

  2013cites this paper
• Monitoring Alzheimer's disease in transgenic mice with ultra high field magnetic resonance imaging

  2013influential citation
• Clinical, Biological, and Imaging Features of Monogenic Alzheimer's Disease

  2013cites this paper
• The Association Between Small Vessel Infarcts and the Activities of Amyloid-β Peptide Degrading Proteases in Apolipoprotein E4 AlleleCarriers

  2013cites this paper
• Endogenous aggregates of amyloidogenic cystatin C variant are removed by THP-1 cells in vitro and induce differentiation and a proinflammatory response.

  2013cites this paper
• Cytotoxic properties of amyloidogenic L68Q cystatin C. A search for therapeutic agents

  2013cites this paper
• The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease

  2013cites this paper
• Genetic Stabilization of Transthyretin, Cerebrovascular Disease, and Life Expectancy

  2013cites this paper
• Oligomeric Pyroglutamate Amyloid-β is Present in Microglia and a Subfraction of Vessels in Patients with Alzheimer's Disease: Implications for Immunotherapy

  2013cites this paper
• Hereditary and sporadic beta-amyloidoses.

  2013cites this paper
• Multiple intracranial hemorrhages in a normotensive demented patient: A probable cerebral amyloid angiopathy

  2012cites this paper
• Preparation of cultured human vascular cells.

  2012cites this paper
• Cerebral amyloid angiopathy manifested as a brain tumour. Clinical and neuropathological characteristics of two cases.

  2012cites this paper
• Role of ligand-based drug design methodologies toward the discovery of new anti- Alzheimer agents: futures perspectives in Fragment-Based Ligand Design.

  2012cites this paper
• Cerebral amyloid angiopathy-associated intracerebral hemorrhage: pathology and management.

  2012cites this paper
• The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders.

  2012cites this paper
• Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer's disease by in vivo magnetic resonance angiography at 17.6 T

  2012cites this paper
• A&bgr;-Degrading Enzymes: Potential for Treatment of Alzheimer Disease

  2011cites this paper
• 18 – Stroke Genetics

  2011cites this paper